SA
ASND icon

Sanctuary Advisors’s Ascendis Pharma A/S ASND Stock Holding History

Sanctuary Advisors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,597
Closed -$203K – 2201
2024
Q4 		$203K Buy
+1,597
New +$210K ﹤0.01% 2242

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanctuary Advisors's ASND Position: Q1 2025 in Review

Sanctuary Advisors sold out of Ascendis Pharma A/S (ASND) in Q1 2025, closing a stake of 1,597 shares — an estimated $203K sold.

Sanctuary Advisors first reported a position in ASND in Q4 2024 and held it in 1 quarter. The position peaked at $203K in Q4 2024. 244 funds tracked by Wall St. Rank hold ASND as of Q1 2025.

  • Sanctuary Advisors reported no remaining Ascendis Pharma A/S position as of Q1 2025 after selling out during the quarter.
  • Sanctuary Advisors sold 1,597 Ascendis Pharma A/S shares in Q1 2025, an estimated $203K.
  • Sanctuary Advisors first reported a position in Ascendis Pharma A/S in Q4 2024 and held it in 1 quarter.
  • Sanctuary Advisors's Ascendis Pharma A/S position peaked at $203K in Q4 2024.
  • 244 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2025.

Based on Sanctuary Advisors's 13F filing for Q1 2025, filed 6 Jan 2026.